Multiple Logistic Regression Analysis of Patient and Provider Variables Associated With Having a PrEP Discussion During a Primary Care Visit
| Variable | Odds Ratio | P Value | 95% Confidence Interval |
|---|---|---|---|
| Saw MSM specialist | 5.05 | 0.002 | 1.81-14.10 |
| Documentation of STI history (positive or negative) | 5.41 | 0.003 | 1.80-16.23 |
| Documentation of condom use (consistent or inconsistent) | 3.32 | 0.015 | 1.27-8.74 |
| Age ≤40 years | 1.74 | 0.340 | 0.55-5.48 |
| African American race | 1.01 | 0.980 | 0.28-3.67 |
Note: Absence of HIV testing and no sexual activity during the study period both perfectly predicted no PrEP discussion and were forced out of the model.
MSM, men who have sex with men; PrEP, pre-exposure prophylaxis (emtricitabine/tenofovir disoproxil fumarate [Truvada]); STI, sexually transmitted infection.